Position in CTMX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,694,152
+$2,694,152 QoQ
Shares Held
573,224
Ownership
0.263%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#41
of 178 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Derivatives in CTMX
reported options exposure · as of Mar 31, 2026CallValue
$4,230,000
CallShares
900,000
PutValue
$1,974,000
PutShares
420,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caption Management, LLC holds $195,300,170 across 69 Biotechnology names. CTMX ranks #17 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
378,480 | $25,615,526 | |
| 2 | IMCR |
Immunocore Holdings plc
|
661,786 | $19,952,847 | |
| 3 | CYTK |
Cytokinetics Inc
|
245,000 | $16,147,950 | |
| 4 | ELVN |
Enliven Therapeutics, Inc.
|
370,000 | $14,504,000 | |
| 5 | SLNO |
Soleno Therapeutics Inc
|
420,143 | $14,066,387 | |
| 6 | CNTA |
Centessa Pharmaceuticals plc
|
274,116 | $10,887,887 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
260,000 | $10,480,600 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
|
272,292 | $7,626,898 |
All Filings in CTMX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,974,000 | 420,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $2,694,152 | 573,224 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $4,230,000 | 900,000 | Call | Sole | 2026-05-15 | |
| 2025-09-30 | $797,181 | 249,900 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $170,250 | 75,000 | Call | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||